Clinical Trials on 乳腺癌女性 in United States
总计28659个结果
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC完全的
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin Ireland完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis完全的
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | 浸润性乳腺癌 | II期乳腺癌 | 乳腺癌女性 | HER2阳性乳腺癌 | III期乳腺癌美国
-
H. Lee Moffitt Cancer Center and Research Institute终止乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | HER-2基因扩增 | 乳腺癌女性 | HER2阳性乳腺癌 | HER-2 蛋白过表达美国
-
H. Lee Moffitt Cancer Center and Research Institute撤销
-
Pfizer主动,不招人
-
Wake Forest University Health SciencesAtrium Health Navicent主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人
-
Dana-Farber Cancer InstituteBreast Cancer Research Foundation尚未招聘
-
Fox Chase Cancer CenterAmerican Cancer Society, Inc.完全的
-
University of Pittsburgh撤销
-
Massachusetts General HospitalPfizer; American Cancer Society, Inc.招聘中
-
H. Lee Moffitt Cancer Center and Research InstituteSaladax Biomedical, Inc.完全的
-
Texas Tech University Health Sciences CenterTexas Tech University完全的
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer Center招聘中
-
University of ArizonaNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; Case Western Reserve University招聘中
-
Wendie BergBreast Cancer Research Foundation主动,不招人
-
Baylor Breast Care Center招聘中乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | 三阴性乳腺肿瘤 | HER2阳性乳腺癌 | 乳腺癌二期 | 乳腺癌女性 | 乳腺癌三期 | 雌激素受体阳性乳腺癌 | 激素受体阳性乳腺癌 | 侵袭性乳腺癌美国
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, Germany终止实体瘤 | 晚期三阴性乳腺癌 | 晚期激素受体阳性/内分泌难治性乳腺癌 | 晚期转移性去势抵抗性前列腺癌 | 晚期铂类耐药卵巢癌美国
-
Adrienne G. WaksGilead Sciences招聘中乳腺癌女性 | 乳腺癌转移 | 她的 2 次阳性乳腺癌美国
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis Pharmaceuticals尚未招聘乳腺癌 | 三阴性乳腺癌 | 乳腺癌女性 | HER2 阴性乳腺癌 | 激素受体阴性乳腺癌三联美国
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of Texas主动,不招人
-
University of WashingtonNational Cancer Institute (NCI)完全的男性乳腺癌 | IV 期乳腺癌 | 三阴性乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌 | 遗传性乳腺癌/卵巢癌 - BRCA1 | 遗传性乳腺癌/卵巢癌 - BRCA2美国
-
National Cancer Institute (NCI)终止